The Pilot Program uses a unique “Human + AI” (HAI) model to interact with patients & monitor progress.
Eve,a healthcare AI companion, announced a partnership with the Ness Care Group, a leading UK Dementia Care organization. The two companies will roll out a program next month that uses AI to diagnose and monitor those suffering from early-stage dementia and mild cognitive impairment (MCI).
“Many people avoid getting screened for dementia,” says Jonathan Hanbury, CEO @Ness, “which means we only detect a small portion of those who are affected,” he added. Waitlists in the UK to see a dementia specialist can be as long as 18 months, and there is little consistency in how the disease is monitored from that point onwards.
Health Technology Insights: United Digestive Partners with eClinicalWorks for AI-Powered healow Genie
“Mental health in older adults is under-diagnosed and under-funded” says Hanbury. “We hope to change that by reaching the most vulnerable and elderly populations in order to slow the development of dementia.”
The program will use Eve – a phone & text-based AI companion – to check in with patients every day.
“The more you talk with Eve the more your relationship grows,” says Ivan Wicksteed, CEO @Eve. A 2024 Harvard study suggests that AI companions like Eve can reduce feelings of loneliness by 20%.
Eve will administer standardized cognitive tests over the phone to measure and monitor brain health and mood.
Health Technology Insights: Laboratory Proficiency Testing Market to Reach $2.1 Billion by 2030
The pilot study will target people over the age of 75 who have some degree of cognitive impairment and will monitor their progress over a four-week period. Some of the respondents will be prompted with daily reminders and behavioural cues to help improve their brain health.
“There are actually a lot of ways we can treat MCI & dementia, provided that we catch it early enough” says Hanbury, a leading voice in this field for over two decades. According to the Lancet Commission (2024) up to 45% of all dementia is “preventable” provided that appropriate actions are taken before it is too late.
“Our vision here” says Wicksteed “is to provide a free, accessible and reliable way for people to measure their cognitive health over time. Monitoring your brain health should be as easy as monitoring your weight.”
Health Technology Insights: Breast Biopsy Devices Market to Hit $3.4 Billion by 2030 with Growth
To participate in our interviews, please write to our HealthTech Media Room at sudipto@intentamplify.com
Source – businesswire
